Baclofen chemical structure
Find information on thousands of medical conditions and prescription drugs.

Baclofen

Baclofen (brand names Kemstro® and Lioresal®) is a derivative of gamma-aminobutyric acid, and is an agonist specific to mammalian but not fruit fly (Drosophila) GABAB receptors. It is used for the treatment of spastic movement, especially in instances of spinal cord injury and in multiple sclerosis. Its beneficial effects result from actions at spinal and supraspinal sites. Baclofen can also be used to treat hiccups. more...

Home
Diseases
Medicines
A
B
Baciim
Bacitracin
Baclofen
Bactrim
Bactroban
Barbexaclone
Barbital
Baros
Basiliximab
Baycol
Beclamide
Beclometasone
Beclovent
Beconase
Beldin
Benadryl
Benazepril
Bendroflumethiazide
Benserazide
Bentiromide
Benylin
Benzaclin
Benzalkonium chloride
Benzocaine
Benzonatate
Betacarotene
Betadine
Betahistine
Betamethasone
Betaxolol
Bextra
Biaxin
Bibrocathol
Bicalutamide
Bicillin
Biclotymol
Biotin
Bisoprolol
Bleomycin
Blocadren
Boldenone
Boniva
Bontril
Bosentan
Bravelle
Brethaire
Brevibloc
Brevicon
Bricanyl
Bromazepam
Bromelain
Bromhexine
Bromocriptine
Brompheniramine
Bronkodyl
Bronopol
BSS
Bucet
Budesonide
Bumetanide
Bupivacaine
Buprenex
Buprenorphine
Buserelin
Buspar
Buspirone
Busulfan
Butalbital
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Description of compound

Baclofen is a white to off-white, odorless or practically odorless crystalline powder, with a molecular weight of 213.66. It is slightly soluble in water, very slightly soluble in methanol, and insoluble in chloroform.

Routes of administration

Baclofen can be administered either orally or intrathecally (directly into the spinal fluid). Intrathecal administration is often indicated in spasticity patients, as very little of the oral dose actually reaches the spinal fluid.

Intrathecal administration is particularly used in patients with multiple sclerosis who have severe painful spasms which are not controllable by oral baclofen. A test dose is given to assess the effect, and if successful a chronic intrathecal catheter in inserted and connected to a computer-controlled implanted pump. The reservoir in the pump can be replenished by percutaneous injuection. These pump systems are quite sophisticated and expensive so careful patient selection is required.

History

Historically Baclofen was designed to be a drug for epilepsy in the 1920’s, and was derived from diazepam (Valium©). The effect on epilepsy was disappointing but it was found that in certain patients spasticity decreased. Baclofen was and is still given orally with variable effects. In the severely affected children, the oral dose is so high that side effects appear and the treatment loses its benefit. How and when Baclofen came to be used in the spinal sack is not really clear but this is now an established method for the treatment of spasticity in many conditions.

How Baclofen works

Baclofen has its effect in the spinal cord, which is the main connection between the brain and then rest of the body. The spinal cord is a reflex system, a feedback loop. The most obvious reflex is the withdrawal to heat. This movement is brisk and not very well controlled. This is what happens in Cerebral Palsy. Without adequate control from the brain, every movement is like a reflex, being rough and uncontrolled. The reflex can spread through the body causing spasms or “arching”. These spasms can be painful and interrupt sleep.

Baclofen works on this reflex circuit. The reflex circuit in the spinal cord contains the Renshaw cells. These cells are very sensitive to a natural chemical produced by the nervous system: GABA, gamma-amino-butyric-acid. GABA slows the reflex circuit down and Baclofen acts like GABA. The dose of intrathecal Baclofen necessary to slow down the reflex circuit is variable but is generally one thousand times smaller than the oral dose.

Pharmacokinetics

The drug is rapidly absorbed after oral administration and is widely distributed throughout the body. Biotransformation is low and the drug is predominantly excreted in the unchanged form by the kidneys.

Read more at Wikipedia.org


[List your site here Free!]


A self-report of quality of life of patients receiving intrathecal baclofen therapy : An article from: Rehabilitation Nursing $20.00 Baclofen Reduces Symptoms of Duodenogastroesophageal Reflux. : An article from: Internal Medicine News $5.95
Intrathecal Baclofen Reduces Spasticity in Stroke. (Patients Able to Walk, Climb Stairs).(Brief Article) : An article from: Internal Medicine News $5.95

Baclofen in outpatient treatment of alcohol withdrawal syndrome
TO THE EDITOR: We read with great interest the article by Asplund et al ("3 Regimens for alcohol withdrawal and detoxification," J Fam Pract ...
Baclofen and Esophageal Reflux in Healthy Persons
The principal cause of esophageal reflux in healthy persons and in patients with reflux disease is transient relaxation of the lower esophageal sphincter ...
PLACE OF INTRATHECAL BACLOFEN TEST FOR ASSESSING NEURO-ORTHOPAEDIC COMPLICATIONS INVOLVING RETRACTION OF THE LOWER LIMBS
Purpose: Multiple deformations of the lower limbs are common orthopaedic complications of central nervous system disease. Assessment is difficult. Intrathecal ...
Intrathecal Baclofen: A New Treatment Approach for Severe Spasticity in Patients with Stroke
ABSTRACT Intrathecal baclofen (ITB) is a relatively new treatment approach that may be useful for treating spasticity in patients with chronic stroke.
Antitussive effect of the GABA-agonist baclofen - gamma-aminobutyric acid
Cough is probably the most common symptom of respiratory disease. Cough associated with acute bacterial respiratory tract infection or chronic obstructive ...
letters
Physical Therapy Needs More Inventors To the Editor: I was pleased to read the article "PT & PTA Inventors: What a Great Idea!" in the July issue of PT ...
Vertigo and motion sickness. Part I: vestibular anatomy and physiology
Abstract Control of the symptoms of vertigo and motion sickness requires consideration of the neurophysiology of areas both intrinsic and extrinsic ...
syndrome of hydrocephalus in young and middle-aged adults (SHYMA), The
Objectives: Currently, headache, nausea/vomiting, visual changes, and altered mental status are accepted as indications for the evaluation of hydrocephalus ...

Home Contact Resources Exchange Links ebay